Sign in
4

Changes in Ownership

Jasper Therapeutics, Inc. Filed Acc 0001213900-23-047573

Options or other derivatives

  • Director acquired 47,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Klein Lawrence Otto · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-07 Grant or award : show line 1 in the form Stock Option (right to buy) +47,000 47,000 D
Loading xslF345X04/ownership.xml…